Subscribe To
Nih says pfizer's paxloid should be first treatment option for certain covid-19 patients
The National Institutes of Health on Wednesday updated its COVID-19 treatment guidelines for patients with mild to moderate forms of COVID-19 who are ...
January 20, 2022, 8:42 am
Nih says pfizer's paxloid should be first treatment option for certain covid-19 patients
The National Institutes of Health on Wednesday updated its COVID-19 treatment guidelines for patients with mild to moderate forms of COVID-19 who are ...
January 20, 2022, 8:42 am
Genmab: ready for more growth in 2022
Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...
December 22, 2021, 11:38 pm
Genmab: ready for more growth in 2022
Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...
December 22, 2021, 11:38 pm
Genmab: ready for more growth in 2022
Genmab has an impressive pipeline of proprietary and partnered programs in development. In addition, the company has developed or helped develop five ...
December 22, 2021, 11:38 pm
Novavax covid vaccine provides antibody response against omicron, data suggests
Novavax said a third dose of its vaccine increased antibodies against omicron 73.5-fold from its initial two shots....
December 22, 2021, 7:53 pm
Novavax covid vaccine provides antibody response against omicron, data suggests
Novavax said a third dose of its vaccine increased antibodies against omicron 73.5-fold from its initial two shots....
December 22, 2021, 7:53 pm
Novavax covid vaccine provides antibody response against omicron, data suggests
Novavax said a third dose of its vaccine increased antibodies against omicron 73.5-fold from its initial two shots....
December 22, 2021, 7:53 pm
Astrazeneca's covid-19 antibody effective against omicron variant
New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody E...
December 16, 2021, 1:27 pm
Astrazeneca's covid-19 antibody effective against omicron variant
New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody E...
December 16, 2021, 1:27 pm
Astrazeneca's covid-19 antibody effective against omicron variant
New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody E...
December 16, 2021, 1:27 pm
Will adagio's covid antibody therapy be too late to the party?
It's quite possible....
December 4, 2021, 7:52 am
Will adagio's covid antibody therapy be too late to the party?
It's quite possible....
December 4, 2021, 7:52 am
Will adagio's covid antibody therapy be too late to the party?
It's quite possible....
December 4, 2021, 7:52 am
Gbs shares are rallying on plans for covid-19 antibody trials after validation study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) antibody te...
November 30, 2021, 1:11 pm
Gbs shares are rallying on plans for covid-19 antibody trials after validation study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) antibody te...
November 30, 2021, 1:11 pm
Gbs shares are rallying on plans for covid-19 antibody trials after validation study
GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) antibody te...
November 30, 2021, 1:11 pm
Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001
TRACON Pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Eucure Biopharma for the development of CTLA-4
October 11, 2021, 8:55 am
Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001
TRACON Pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Eucure Biopharma for the development of CTLA-4
October 11, 2021, 8:55 am
Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001
TRACON Pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Eucure Biopharma for the development of CTLA-4
October 11, 2021, 8:55 am